(Q40569367)

English

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems

scientific article published on April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems (English)

1 reference

Europe PubMed Central

21 September 2017

James P. Allison

12

object named as

James P Allison

0 references

Miguel-Angel Perales

object named as

Miguel-Angel Perales

6

0 references

Jedd D. Wolchok

2

object named as

Jedd D Wolchok

1 reference

Europe PubMed Central

21 September 2017

author name string

Polly D Gregor

1

1 reference

Europe PubMed Central

21 September 2017

Cristina R Ferrone

3

1 reference

Europe PubMed Central

21 September 2017

Heidi Buchinshky

4

1 reference

Europe PubMed Central

21 September 2017

Jose A Guevara-Patiño

5

1 reference

Europe PubMed Central

21 September 2017

Fariborz Mortazavi

7

1 reference

Europe PubMed Central

21 September 2017

Dean Bacich

8

1 reference

Europe PubMed Central

21 September 2017

Warren Heston

9

1 reference

Europe PubMed Central

21 September 2017

Jean-Baptiste Latouche

10

1 reference

Europe PubMed Central

21 September 2017

Michel Sadelain

11

1 reference

Europe PubMed Central

21 September 2017

Howard I Scher

13

1 reference

Europe PubMed Central

21 September 2017

Alan N Houghton

14

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

22

1 reference

Europe PubMed Central

21 September 2017

1700-1708

1 reference

Europe PubMed Central

21 September 2017

13-14

1 reference

Europe PubMed Central

21 September 2017

Cancer antigens: immune recognition of self and altered self

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Tumor immunity and autoimmunity induced by immunization with homologous DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Coupling and uncoupling of tumor immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Vaccine therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Cytokines and costimulatory molecules as genetic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Next generation DNA vaccines for HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

The role of CTLA-4 in the regulation and initiation of T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Pathologic progression of autochthonous prostate cancer in the TRAMP model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

The role of lipopolysaccharide in T-cell responses following DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Selection of Successive Tumour Lines for Metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

based on heuristic

inferred from DOI database lookup

Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.10.048

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40569367&oldid=2098290887"